论文信息 - High-performance liquid chromatographic assay of alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol (BMY 14802), a potential antipsychotic drug, in monkey and rat plasma. - 字舞流文

High-performance liquid chromatographic assay of alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol (BMY 14802), a potential antipsychotic drug, in monkey and rat plasma.

K. Pittman | K. Dandekar | S. Kaul | U. Shukla | J. Janiszewski

[1] K. Midha,et al. Interconversion between haloperidol and reduced haloperidol in humans. , 1987, Journal of clinical psychopharmacology.

[2] Kenneth A. Pittman,et al. Management of Pharmacokinetic Data Using HP-3357/Mainframe Ibm Interfacing , 1987 .

[3] R. Matthews,et al. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function. , 1986, The Journal of pharmacology and experimental therapeutics.

[4] F. J. White,et al. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies. , 1988, The Journal of pharmacology and experimental therapeutics.

[5] Duncan P. Taylor,et al. Potential antipsychotic BMY 14802 selectively binds to sigma sites , 1987 .